Evidence map›Paper›PMID 32172616›Full record

ArticleHemoglobin2020

Hb S/

André R Belisário, Anna B Carneiro-Proietti, Ester Cerdeira Sabino, Aderson Araújo, Paula Loureiro, Cláudia Máximo, Miriam V Flor-Park, Daniela D O W Rodrigues, Mina Cintho Ozahata, Christopher McClure and 5 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Hemoglobin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

André R BelisárioFundação Hemominas, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0003-0166-4258
Anna B Carneiro-ProiettiFundação Hemominas, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0003-4302-5817
Ester Cerdeira SabinoFaculdade de Medicina (FMUSP), Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-2623-5126
Aderson AraújoFundação Hemope, Pernambuco, Brazil.
Paula LoureiroFundação Hemope, Pernambuco, Brazil.ORCID http://orcid.org/0000-0003-1849-0047
Cláudia MáximoHemorio, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0002-9351-3766
Miriam V Flor-ParkHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Instituto da Criança, São Paulo, Brazil.ORCID http://orcid.org/0000-0001-5558-6166
Daniela D O W RodriguesFundação Hemominas, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0003-3062-2954
Mina Cintho OzahataDepartamento de Ciências da Computação, Universidade de São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-1272-2380
Christopher McClureResearch Triangle Institute (RTI), Rockville, MD, USA.
Rosimere Afonso MotaFundação Hemominas, Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-3955-6036
Isabel C Gomes MouraFaculdade Ciências Médicas de Minas Gerais, Brazil.ORCID http://orcid.org/0000-0002-5549-3426
Brian CusterVitalant Research Institute, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6251-366X
Shannon KellyVitalant Research Institute, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-2049-3992
Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component Brazil
Fundação Centro de Hematologia e Hemoterapia de Minas Gerais · BRFundação Hemopa · BRUniversidade de São Paulo · BRFaculdade de Ciências Médicas de Minas Gerais · BRHemorio · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRPacific Research Institute · USRTI International · USUniversity of California, San Francisco · US

Funding

NHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007I
6 · The paper itself

Abstract

We described the clinical, laboratory and molecular characteristics of individuals with Hb S (

Indexed as

MutationAdolescentAdultAllelesAnemia, Sickle Cellbeta-Globinsbeta-ThalassemiaBrazilChildCodonCohort StudiesDNA Mutational AnalysisFemaleGene ExpressionGene FrequencyGenotypebeta-GlobinsCodonHemoglobin, SickleClinical eventsHb S/β0-thalassemia (Hb S/β0-thal)Hb S/β+-thalassemia (Hb S/β+-thal)sickle cell diseasethalassemia mutation

Identifiers

PMID32172616
PMCPMC7225056
OpenAlexW3012345555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.